Psychedelics-Assisted Therapy

Dua Lipa Interviews 'Queen Of Psychedelics' Amanda Feilding On Her 6-Decade Exploration Of Psychoactive Drugs
A Chapter In Psychedelics History: Alexander Shulgin's 'Blending' Of Sensory Experiences With Science And Chemistry
Seelos Dosing Participants In Psychedelics Study, Seeks Japanese Subjects In Major Depression Therapy
A Chapter In Psychedelics History: Alexander Shulgin's 'Blending' Of Sensory Experiences With Science And Chemistry
Seelos Dosing Participants In Psychedelics Study, Seeks Japanese Subjects In Major Depression Therapy
Psychedelics Precision Psychiatry Company Nabs $60M In Series B Round For Advanced Clinical Trials
Clearmind Teams With Yissum, University of Jerusalem On 2 Psychedelic R&D Projects

Psychedelics-Assisted Therapy Recent News

Psychedelics Company Revive Raises $3.2M To Target Infectious Diseases, Disorders
Life sciences company Revive Therapeutics Ltd. (OTCQB: RVVTF) raised funds to treat infectious diseases and rare disorders, including meth addiction.<
2 Psychedelics Companies Tout Advanced Clinical Trials, Progress With Key Products
Two psychedelics companies have shared their updates and key milestones to be reached this 2023.
Comparing Psychedelics' Administration Routes: Are Intramuscular Injections More Effective Than Intravenous?
Short-acting psychedelics biotech Small Pharma Inc. (OTCQB: DMTTF) has dosed the first patient in its Phase 1 clinical trial assessing intramuscular (IM) versus intravenous (IV) administration of its novel DMT-based synthetic compound.
Psyched: NY Discusses Regulations, MDMA For PTSD Aims For Legalization, Shrooms For Eating Disorders & More
Guess Which East Coast State Is Now Discussing Legalizing Psychedelics? Decriminalizing psychedelics is one thing, but fully legalizing them is another. That's currently a measure before New York's Senate Health Committee.
Bipartisan Psychedelics Caucus Created In Congress
Psychedelics have made it to Capitol Hill. On Thursday Congress announced the creation of a Congressional Psychedelics Advancing Clinical Treatments (PACT) Caucus.
This New Psychedelic Therapy Program Will Accompany Patients In Their Healing Journey For A Whole Year
Psychedelics-assisted therapy provider Field Trip Health & Wellness Ltd. has launched Freedom by Field Trip, a novel and unmatched one-year hybrid program combining ketamine-assisted therapy (KAP) with holistic wellness support.
Novel Psychedelic Compound For The Treatment Of Fibromyalgia Begins Dosing In Safety Trial
Developmental-stage psychedelics biotech company Silo Pharma Inc. (NASDAQ: SILO) has begu
Atai Life Sciences' Q3 2022 Financials & Business Update, 'Strong Capability To Execute'
Clinical-stage psychedelics company atai Life Sciences N.V. (NASDAQ: ATAI) reported its financial results for the quarter ended September 30, 2022 and shared business developments.
Psychedelics Investment Holder Blackhawk Growth Hosts Meeting For Potential Subsidiary Spin-Out
Blackhawk Growth Corp. (OTCMKTS: BLRZF), an investment holding company focused on acquiring and developing high-growth companies in the health, cannabis and psychedelics sectors in the US and Canada, announced it intends to complete a spin-out transaction of its wholly-owned subsidiaries MindBio Therapeutics Pty. Ltd.
Psyched: Brock Pierce Joins Psychedelic VC, Colorado's Psychedelics Legalization, Zappy Zapolin's Open Letter & More
Crypto Billionaire Brock Pierce Joins Psychedelic Venture Fund, Says 'Potential Reward Is Immeasurable'
Psychedelic Therapy Frontiers Podcast Is Back, Check Out Upcoming Episodes
Mental health care company Numinus Wellness (OTCQX: NUMIF) is re-launching its "Psychedelic Therapy Frontiers" podcast series dedicated to exploring the psychedelics renaissance and cultivating mind, body and spiritual health with new hosts, expanded topics and fr
Psyched: Top Psychedelics Execs., 50% Of Americans Support Medical Psychedelics, Cary Grant's LSD Therapy & More
15 Global Psychedelics Executives To Keep An Eye On In 2022
Australian Psychedelics: Incannex Business & Financials, New Research Center For Mushrooms & Eating Disorders
Clinical-stage biopharma company Incannex Healthcare Ltd. (NASDAQ: IXHL) shared its quarterly activities report and appendix 4C for the period ended 30 September 2022, noticeably applying for several U.S.
Alberta Becomes First Canadian Province To Regulate Psychedelics-Assisted Therapy
As of January 2023, Canada’s 4th largest province will be the first to offer supervised treatments involving psychedelic substances such as psilocybin, MDMA, LSD, mescaline, DMT and ketamine to those among its 4.5 million population suffering from mental health disorders.